Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Individuals with any of the following conditions should consult with their healthcare provider before use and may not be eligible for treatment: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Known hypersensitivity to GLP-1 or GLP-1/GIP medications or any formulation components, including additives such as vitamin B12 or cobalt Pregnancy or plans to become pregnant (therapy should be discontinued at least two months prior to planned pregnancy) Diabetic ketoacidosis (DKA) or type 1 diabetes Severe gastrointestinal disease (including gastroparesis or active inflammatory bowel disease) Severe cardiovascular disease (including unstable coronary artery disease or heart failure) Recent bariatric or gastrointestinal surgery within the past six months Active cancer currently undergoing chemotherapy or radiation treatment This list is not comprehensive
Tirzepatide is a medication that targets two hormones involved in blood sugar regulation: GLP-1 and GIP
clinic sources cite weight shift after two doses In trials, ~15% body weight over 68 weeks
it demands a dedicated partner committed to your long-term biological health
Digestive Side Effects Nausea, vomiting, and diarrhea are common with tirzepatide, especially during dose changes
US$ 20.39
US$ 22.51
US$ 25.33
US$ 21.44
US$ 24.92
